Avecure Flexible Microwave Ablation Probe For Lung Nodules
NCT05281237
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Stage I - II Primary Lung Cancer
- Stage I Lung Cancer
- Stage II Lung Cancer
- Lung Cancer Stage I
- Lung Cancer Stage II
- Lung Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Beth Israel Deaconess Medical Center
- Last updated on ClinicalTrials.gov
- April 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Beth Israel Deaconess Medical Center · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.